Dark Reading is part of the Informa Tech Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them.Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Operational Security //

Policy

4/17/2017
06:06 PM
Curtis Franklin Jr.
Curtis Franklin Jr.
Curt Franklin
50%
50%

FDA Warns Abbott on IoT Vulnerability & More

The FDA delivered a strongly worded warning to Abbott Labs about continuing vulnerabilities and defects in implantable devices.

Cleaning up a mess is never fun. Cleaning up an inherited mess is worse, and that's the position in which Abbott Labs finds itself after a harsh letter of warning from the US FDA.

At issue are the pacemakers and internal defibrillators sold by St. Jude Medical before the company was acquired by Abbott Labs in January 2017. According to the FDA's Warning Letter, St. Jude Medical (now Abbott Labs) has failed to correct previously noted problems in the battery and cybersecurity vulnerabilities in both pacemakers and internal defibrillators. The letter, dated April 12, noted that the company has failed to either correct the problems or implement procedures to insure that they do not recur. In addition, the letter cites Abbott labs for selling a small number of units already under a recall order.

In January, the FDA confirmed that the St. Jude Medical devices contained software with vulnerabilities that could allow an unauthorized third party to gain control of the pacemaker or defibrillator and quickly run down the battery or deliver a series of shocks at the wrong time. At the time, St. Jude said that it had developed a software patch that could be automatically applied to devices through the [email protected] transmitter each patient uses with the devices. Abbott Labs also said that it was working with both the FDA and DHS to improve device security.

The original vulnerability report, published by investment firm Muddy Waters Research and based on "ethical hacking" from MedSec, was controversial because Muddy Waters released the information, which described vulnerability to man-in-the-middle attacks in the implantable devices, in a statement regarding stock sales and purchases rather than in a private message to either St. Jude Medical or the FDA.

The latest FDA warning letter indicates that Abbott Labs has not dealt with the problem to the satisfaction of the FDA. On a larger scale, this is the sort of IoT security issue that many experts have warned about: critical components containing serious vulnerabilities deployed in difficult-to-update scenarios. Companies that sell IoT systems, as well as those that are their customers, are likely to be watching the interaction of Abbott Labs and the FDA to see how future IoT vulnerabilities will be dealt with by regulators and industry.

— Curtis Franklin, Security Editor, Light Reading

Comment  | 
Print  | 
More Insights
Comments
Oldest First  |  Newest First  |  Threaded View
Edge-DRsplash-10-edge-articles
I Smell a RAT! New Cybersecurity Threats for the Crypto Industry
David Trepp, Partner, IT Assurance with accounting and advisory firm BPM LLP,  7/9/2021
News
Attacks on Kaseya Servers Led to Ransomware in Less Than 2 Hours
Robert Lemos, Contributing Writer,  7/7/2021
Commentary
It's in the Game (but It Shouldn't Be)
Tal Memran, Cybersecurity Expert, CYE,  7/9/2021
Register for Dark Reading Newsletters
White Papers
Video
Cartoon
Current Issue
How Enterprises are Attacking the Cybersecurity Problem
Concerns over supply chain vulnerabilities and attack visibility drove some significant changes in enterprise cybersecurity strategies over the past year. Dark Reading's 2021 Strategic Security Survey showed that many organizations are staying the course regarding the use of a mix of attack prevention and threat detection technologies and practices for dealing with cyber threats.
Flash Poll
Twitter Feed
Dark Reading - Bug Report
Bug Report
Enterprise Vulnerabilities
From DHS/US-CERT's National Vulnerability Database
CVE-2021-33988
PUBLISHED: 2021-10-19
Cross Site Scripting (XSS). vulnerability exists in Microweber CMS 1.2.7 via the Login form, which could let a malicious user execute Javascript by Inserting code in the request form.
CVE-2020-12141
PUBLISHED: 2021-10-19
An out-of-bounds read in the SNMP stack in Contiki-NG 4.4 and earlier allows an attacker to cause a denial of service and potentially disclose information via crafted SNMP packets to snmp_ber_decode_string_len_buffer in os/net/app-layer/snmp/snmp-ber.c.
CVE-2021-29912
PUBLISHED: 2021-10-19
IBM Security Risk Manager on CP4S 1.7.0.0 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 207828.
CVE-2021-38911
PUBLISHED: 2021-10-19
IBM Security Risk Manager on CP4S 1.7.0.0 stores user credentials in plain clear text which can be read by a an authenticatedl privileged user. IBM X-Force ID: 209940.
CVE-2021-3746
PUBLISHED: 2021-10-19
A flaw was found in the libtpms code that may cause access beyond the boundary of internal buffers. The vulnerability is triggered by specially-crafted TPM2 command packets that then trigger the issue when the state of the TPM2's volatile state is written. The highest threat from this vulnerability ...